0001562180-19-006220.txt : 20191220 0001562180-19-006220.hdr.sgml : 20191220 20191220175222 ACCESSION NUMBER: 0001562180-19-006220 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191220 FILED AS OF DATE: 20191220 DATE AS OF CHANGE: 20191220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DAVIS JOHN C. JR CENTRAL INDEX KEY: 0001741287 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38541 FILM NUMBER: 191302936 MAIL ADDRESS: STREET 1: C/O MAGENTA THERAPEUTICS STREET 2: 50 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Magenta Therapeutics, Inc. CENTRAL INDEX KEY: 0001690585 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 TECHNOLOGY SQUARE STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-201-2700 MAIL ADDRESS: STREET 1: 100 TECHNOLOGY SQUARE STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-12-20 false 0001690585 Magenta Therapeutics, Inc. MGTA 0001741287 DAVIS JOHN C. JR C/O MAGENTA THERAPEUTICS, INC. 100 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 false true false false Chief Medical Officer Common Stock 2019-12-20 4 M false 114.00 9.49 A 8418.00 D Common Stock 2019-12-20 4 M false 805.00 9.49 A 9223.00 D Common Stock 2019-12-20 4 S false 919.00 15.00 D 8304.00 D Stock Option (Right to Buy) 9.49 2019-12-20 4 M false 805.00 0.00 D 2028-04-25 Common Stock 805.00 236239.00 D Stock Option (Right to Buy) 9.49 2019-12-20 4 M false 114.00 0.00 D 2028-04-25 Common Stock 114.00 236125.00 D This trade is pursuant to an active 10b5-1 plan. 25% vested on February 16, 2019 with the remaining 75% vesting in 12 equal quarterly installments thereafter. /s/ Zoran Zdraveski, Attorney-in-Fact for John C. Davis, Jr. 2019-12-20